Abstract: A stringer for use in a board comprising an internal core and an outer skin, the stringer comprising a first compressible side member adjacent the outer skin on a first side of the board and a second compressible side member adjacent the outer skin on a second opposite side of the board. A central member is provided extending from a location adjacent the first member to a location adjacent the second side member, the first and second side members being relatively flexible in relation to the central member. Longitudinal flexing of the board results in compression of the first and second side members by the central member such that as the amount of flexing increases, the force transferred through the first and second side members from the outer skin to the central member increases, thereby increasing the stiffness of the board.
Abstract: Novel compositions containing conjugated linoleic acids are efficacious as animal feed additives and human dietary supplements. Linoleic acid is converted to its conjugated forms in which the resulting composition is low in certain unusual isomers compared to conventional conjugated linoleic products.
Type:
Grant
Filed:
April 18, 2002
Date of Patent:
August 26, 2003
Assignee:
Natural Corporation
Inventors:
Asgeir Saebo, Carl Skarie, Daria Jerome, Gudmunder Haroldsson
Abstract: Novel compositions containing conjugated linoleic acids are efficacious as animal feed additives and human dietary supplements. Linoleic acid is converted to its conjugated forms in which the resulting composition is low in certain unusual isomers compared to conventional conjugated linoleic products. In addition, the inventions provides compositions that are prepared according to a novel method that controls oxidation of CLA into volatile organic compounds as well as containing metal oxidant chelators to control oxidation during storage.
Abstract: This invention provides method of treatment and prophylaxis of both insulin (Type I) and non-insulin dependent (type II) diabetes mellitus, by administration of conjugated linoleic acid (CLA) in the form of pure isomers, selected isomer mixtures or non-selected isomer mixtures. The conjugated linoleic acids may be administered alone, or in combination with other diabetes therapeutic regimes.
Type:
Grant
Filed:
February 22, 2000
Date of Patent:
August 27, 2002
Assignee:
Natural Corporation
Inventors:
Jan Remmereit, Jan Wadstein, Jo Klaveness
Abstract: A conjugated linoleic acid is prepared in industrial scale as a hydrolyzed isomerized product for blending into bulk domestic animal feeds. The CLA-containing isomerized hydrolyzed oil from sunflower and safflower seeds has sufficiently low levels of phosphatides and sterols to permit crude processing and incorporation into feeds of an undried, undistilled oil fraction without toxic or unpalatable effects.